Acylgycerophospholipids for treating symptoms concomitant with cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090298793A1
SERIAL NO

11989125

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of acylglycerophospholipids, in particular of hydrogenated acylglycerophospholipids and of phospholipids with a high omega-3 fatty acid content, for the production of a medicament for treating symptoms concomitant with cancer, in particular for treating tumour cachexia, cancer-related problems and pain, and for the prophylaxis of tumour growth and metastasis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KTB TUMORFORSCHUNGSGESELLSCHAFT MBHFREIBURG FREIBURG BADEN-WURTTEMBERG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Massing, Ulrich Merzhausen , DE 16 107

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation